 |
 |
 |
For Market’s Latest Update Join Us on Telegram
 |
IPO GMP
IPO is a Mainboard IPO, the company will raise up to via this IPO. The IPO comprises a fresh issue of , and an offer for sale (OFS) of shares (amount) .
IPO will open for subscription on and close on . Basis of allotment will be decided on , initiation of refund will begin on and finally IPO will be listed on at . is the book running lead manager and is the registrar of the IPO.
Total shares offered by IPO is . Out of which is reserved for retail, is reserved for HNI (NII), is reserved for QIB.
IPO Price Band and Market Lot
has set a price band of and lot size is of . Retail investors can bid for a minimum of lots ( shares), requiring minimum investment of , and maximun upto lots ( shares), requiring maximum investment of . Small HNI investors can bid for a minimum of lots ( shares), requiring an investment of , small hni (shni) investors can bid for a maximum of lots ( shares), requiring an investment of and big hni (bHNI) investors can bid for a minimum of Lots ( shares), requiring an investment of . Calculated at the cut-off price (the upper end of the price band).
IPO Subscription Status Today (Live)
IPO GMP (Grey Market Premium) Today (Live)
Visit us daily to get the latest update on IPO GMP. IPO GMP started, and here you can get the latest update of IPO GMP.
IPO GMP today or grey market premium, and the Latest GMP Data pattern is available here.
- Price Band of IPO is .
- Current GMP (Grey Market Premium) for IPO is:
- It is a premium for the IPO cut-off price .
- As per IPO Taday’s GMP Data, the estimated listing price of IPO shares can be:
- Estimated listing price calculated as IPO cutoff price or allotment price: + IPO current GMP: .
| Nephrocare Health Services IPO GMP | ||
| Date | GMP (₹) | Listing Price (₹-Estimated) |
| Today | 38 | |
| 17 December 2025 | 38 | |
| 16 December 2025 | 38 | |
| 15 December 2025 | 36 | |
| 14 December 2025 | 35 | |
| 13 December 2025 | 33.50 | |
| 12 December 2025 | 30 | |
| 11 December 2025 | 11.50 | |
| 10 December 2025 | 15 | |
| 9 December 2025 | 0 | |
| 8 December 2025 | 0 | |
| 7 December 2025 | 0 | |
| 6 December 2025 | 0 | |
| 5 December 2025 | 0 | |
| 4 December 2025 | 0 | |
| 30 Sep 25 in crore | 31 Mar 2025 in crore | 31 Mar 24 in crore | 31 Mar 23 in crore | |
|---|---|---|---|---|
| Assets | 1,193.68 | 996.46 | 806.02 | 666.23 |
| Revenue | 483.97 | 769.92 | 574.72 | 443.26 |
| Profit After Tax | 14.23 | 67.1 | 35.13 | -11.79 |
| EBITDA | 110.31 | 166.64 | 99.66 | 48.6 |
| Net Worth | 716.06 | 594.21 | 423.55 | 384.73 |
| Total Borrowing | 207.04 | 225.8 | 243.37 | 196.21 |
| Reserves & Surplus | 704.14 | 578.68 | 408.57 | 383.5 |
| IPO Time Table (Tentative) | |
| IPO Open Date | |
| IPO Close Date | |
| Basis of Allotment Date | |
| Initiation of Refunds | |
| Credit of Share to Demat Account | |
| IPO Listing Date | |
| IPO Cut-off time (UPI mandate confirmation) | |
| IPO Reservation | |
| Retail Quota | |
| NII Quota | |
| QIB Quota | |
| Total | |
| IPO Price | |
| Face Value | |
| Price Band | |
| Lot Size | |
| IPO Issue Type | |
About (Company Overview)
Nephrocare Health Services Limited founded in 2009 and headquartered in Hyderabad, is a leading Indian specialty healthcare company focused on providing dialysis and comprehensive renal care services through a large network of dedicated kidney care centres. The company operates under the “NephroPlus” brand and has grown into one of Asia’s largest dialysis providers by treatment volumes.
Nephrocare Health’s network spans hundreds of clinics across multiple states of India and union territories, serving tens of thousands of chronic kidney disease patients on a recurring basis. The company also has international presence such as the Philippines, Uzbekistan, Nepal and Saudi Arabia. It reflects company’s ambition to build a scalable, pan‑regional renal care platform.
The company offers a full suite of dialysis modalities including in clinic haemodialysis, home haemodialysis, hemodiafiltration, holiday dialysis for travelling patients, and mobile or on call dialysis services designed to improve access and continuity of care. Its model combines standalone dialysis centres with in‑hospital units set up in partnership with leading hospitals, enabling wide geographic reach across metros, tier‑2 and tier‑3 cities.
IPO Frequently Asked Questions
The latest Grey Market Premium (GMP) of IPO is .
It is a premium to the IPO cut-off price . GMP gives a rough estimate of the premium at which the stock might list. It’s not guaranteed but often aligns with market sentiment.
As per latest GMP data, the expected return for IPO can be .
Expected listing listing price for share can be .
According to latest GMP data pattern expected listing price and profit per share for IPO can be . Expected listing price is calculated by adding the GMP to the IPO issue price. Estimated listing price = IPO issue price + current GMP. This value changes as the GMP fluctuates.
GMP is an unofficial indicator and can be manipulated. It should never be the sole reason to apply. Always consider fundamentals and your risk tolerance. Subscription demand, financial performance, market sentiment, peer valuation, and overall liquidity can impact the GMP trend.
Disclaimer:
- Grey market premium (GMP) indicates investors are willing to pay more than the issue price.
- A negative GMP suggests that the IPO’s share is likely to be listed on the stock exchange at a discount, and a positive Grey Market Premium suggests that the IPO’s share is likely to be listed on the stock exchange at a profit.
- Do not subscribe for IPO by just seeing the premium Price, It can change anytime
- We do not trade/deal or buy/sell IPO forms in the grey market and GMP prices shown here are gathered from various sources.